Home / Cancer and immune system / Certolizumab Pegol
ATC L04AB05 · Immunosuppressants
Certolizumab Pegol shortage
As of 31 Oct 2026, Certolizumab Pegol has a reported shortage in 1 of the 5 countries we track (Belgium), covering 3 products.
Countries1/5
Products3packs or presentations
Short since3 Dec 202423 months ago
Earliest return31 Oct 2026company estimate
No return date0products
Main reasonOther
Timeline
Belgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Cimzia 200 mg (Orifarm) inj. sol. s.c. pre-filled syr. 2 x 1 ml | UCB Pharma | 3 Dec 2024 | 31 Oct 2026 | Other Other reason |
| BE | Cimzia 200 mg (Abacus Medicine) inj. sol. s.c. pre-filled pen 2 x 1 ml Autoclicks | UCB Pharma | 1 Jan 2025 | 31 Dec 2026 | Other Other reason |
| BE | Cimzia 200 mg (Abacus Medicine) inj. sol. s.c. pre-filled syr. 2 x 1 ml | UCB Pharma | 1 Jan 2025 | 31 Dec 2026 | Other Other reason |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.